Author:
Vega Eduardo A.,Kutlu Onur C.,Salehi Omid,James Daria,Alarcon Sylvia V.,Herrick Beth,Krishnan Sandeep,Kozyreva Olga,Conrad Claudius
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Gillen S, Schuster T, Meyer Zum Buschenfelde C, Friess H, Kleeff J. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010;7(4):e1000267. https://doi.org/10.1371/journal.pmed.1000267.
2. National Comprehensive Cancer Network. Pancreatic Adenocarcinoma (Version 1.2020). In: NCCN Clinical Practice Guidelines in Oncology. https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf. Accessed December 13, 2019 2019.
3. Lim KH, Chung E, Khan A, Cao D, Linehan D, Ben-Josef E et al. Neoadjuvant therapy of pancreatic cancer: the emerging paradigm? Oncologist. 2012;17(2):192–200. https://doi.org/10.1634/theoncologist.2011-0268.
4. Kato H, Usui M, Isaji S, Nagakawa T, Wada K, Unno M et al. Clinical features and treatment outcome of borderline resectable pancreatic head/body cancer: a multi-institutional survey by the Japanese Society of Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2013;20(6):601–10. https://doi.org/10.1007/s00534-013-0595-1.
5. Casadei R, Di Marco M, Ricci C, Santini D, Serra C, Calculli L et al. Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which Failed to Achieve Accrual Targets. J Gastrointest Surg. 2015;19(10):1802–12. https://doi.org/10.1007/s11605-015-2890-4.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献